The role of polymer/drug interactions on the sustained release from poly(dl-lactic acid) tablets

European Polymer Journal

Volumn 42, Issue 12, 2006, Pages 3269-3276

  Proikakis, C S ^a   Tarantili, P A ^a   Andreopoulos, A G ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Biodegradable polymers; Erosion; Poly(lactic acid); Sustained drug release; Swelling

Indexed keywords

DIFFUSERS (FLUID); DRUG DOSAGE; DRUG PRODUCTS; EROSION; MOLECULAR WEIGHT; ORGANIC ACIDS; SOLUBILITY; SOLUTIONS; SWELLING;

BIODEGRADABLE POLYMERS; POLY(LACTIC ACID); SUSTAINED DRUG RELEASE;

POLYMERS;

EID: 33750699651     PISSN: 00143057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpolymj.2006.08.023     Document Type: Article

References (34)

1. Baras B., Benoit M.-A., and Gillard J. Parameters influencing the antigen release from spray-dried poly(dl-lactide) microparticles. Int J Pharm 200 1 (2000) 133-145
2. Sendil D., Wise D.L., and Hasirci V. Assessment of biodegradable controlled release rod systems for pain relief applications. J Biomater Sci 13 1 (2002) 1-15
3. Gümüşderelioǧlu M., and Deniz G. Sustained release of mitomycin-C from poly(dl-lactide)/poly(dl-lactide-co-glycolide) films. J Biomater Sci 11 10 (2000) 1039-1050
4. Xiong X.Y., Tam K.C., and Gan L.H. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J Controlled Release 103 1 (2005) 73-82
5. Jalil R., and Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsulation 7 3 (1990) 297-325
6. Shah S.S., Cha Y., and Pitt C.G. Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery?. J Controlled Release 18 3 (1992) 261-270
7. Kissel T., Brich Z., Bantle S., Lancranjan I., Nimmerfall F., and Vitt P. Parenteral depot-systems on the basis of biodegradable polyesters. J Controlled Release 16 1-2 (1991) 27-42
8. Li S., Girod-Holland S., and Vert M. Hydrolytic degradation of poly(dl-lactic acid) in the presence of caffeine base. J Controlled Release 40 1-2 (1996) 41-53
9. Miyajima M., Koshika A., Okada J., Kusai A., and Ikeda M. Factors influencing the diffusion-controlled release of papaverine from poly(l-lactic acid) matrix. J Controlled Release 56 1-3 (1998) 85-94
10. Proikakis C.S., Mamouzelos N.J., Tarantili P.A., and Andreopoulos A.G. Stability of dl-poly(lactic acid) in aqueous solutions. J Appl Polym Sci 87 5 (2003) 795-804
11. Proikakis C.S., Mamouzelos N.J., Tarantili P.A., and Andreopoulos A.G. Swelling and hydrolytic degradation of poly(d,l-lactic acid) in aqueous solutions. Polym Degrad Stab 91 3 (2006) 614-619
12. Takka S., Rajbhandari S., and Sakr A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur J Pharm Biopharm 52 1 (2001) 75-82
13. Ubrich N., Bouillot Ph., Pellerin C., Hoffman M., and Maincent Ph. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Controlled Release 97 2 (2004) 291-300
14. Tunçay M., Çaliş S., Kaş H.S., Ercan M.T., Peksoy I., and Hincal A.A. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharam 195 1-2 (2000) 179-188
15. Palomo M.E., Ballesteros M.P., and Frutos P. Analysis of diclofenac sodium derivatives. J Pharm Anal 21 1 (1999) 83-94
16. Liu C.-H., Kao Y.-H., Chen S.-C., Sokoloski T.D., and Sheu M.-T. In vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets. J Pharm Pharmacol 47 5 (1995) 360-364
17. Dangprasirt P., and Ritthidej G.C. Development of diclofenac sodium controlled release solid dispersion tablet using optimization strategy. Drug Dev Ind Pharm 23 8 (1997) 843-848
18. Andreopoulos A.G., Hatzi E., and Doxastakis M. Controlled release of salicylic acid from poly(dl-lactide). J Mater Sci: Mater Medic 12 3 (2001) 233-239
19. Savaş H., and Güven O. Investigation of active substance from poly(ethylene oxide) hydrogels. Int J Pharm 224 1-2 (2001) 151-158
20. Sato Y., Kawashima Y., Takeuchi H., and Yamamoto H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the solvent diffusion method. Eur J Pharm Biopharm 55 3 (2003) 297-304
21. Yoshizawa T., Shin-ya Y., Hong K.-J., and Kajiuchi T. pH- and temperature-sensitive release behaviors from polyelectrolyte complex films composed of chitosan and PAOMA copolymer. Eur J Pharm Biopharm 59 2 (2005) 307-313
22. Lamprecht A., Torres H.R., Schäfer U., and Lehr C.-M. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease. J Controlled Release 69 3 (2000) 445-454
23. Clemett D., and Markham A. Prolonged-release Mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Drugs 59 4 (2000) 929-956
24. Proikakis C.S., Tarantili P.A., and Andreopoulos A.G. Synthesis and characterization of low molecular weight polylactic acid. J Elastom Plast 34 1 (2002) 49-63
25. a values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry. Rapid Commun Mass Spectrom 17 23 (2003) 2639-2648
26. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 50 (1961) 874-875
27. Baker R.W. Diffusion controlled systems in controlled systems in controlled release of biologically active agents (1987), Wiley, New York p. 39-83
28. Gallagher K.M., and Corrigan O.I. Mechanistic aspects of the release of levamisole hydrochloride from biodegradable polymers. J Controlled Release 69 2 (2000) 261-272
29. Vogelpoel H., Welink J., Amidon G.L., Junginger H.E., Midha K.K., Möller H., et al. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci 93 8 (2004) 1945-1956
30. Bodmeir R., Oh K.H., and Chen H. The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems. Int J Pharm 51 1 (1989) 1-8
31. Miyajima M., Koshika A., Okada J., Kusai A., and Ikeda M. The effects of drug physico-chemical properties on release from copoly (lactic/glycolic acid) matrix. Int J Pharma 169 2 (1998) 255-263
32. Miyajima M., Koshika A., Okada J., and Ikeda M. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(l-lactic acid) matrix. J Controlled release 61 3 (1999) 295-304
33. Miyajima M., Koshika A., Okada J., and Ikeda M. Mechanism of drug release from poly(l-lactic acid) matrix containing acidic or neutral drugs. J Controlled Release 60 2-3 (1999) 199-209
34. Frank A. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 54 1 (2005) 36-46